- 1.2 Health workforce1.6 Vaccine safety2.1 Political and financial commitment2.2 Demand for immunization3.2 High & equitable coverage4.1 Life-course vaccination5.1 Outbreak detection and response6.1 Healthy global markets for vaccines6.2 Financial resources for imm. programmes6.3 Imm. expenditure from domestic resources7.1 Capacity for innovation
Type to select a Country
Impact Goal 3: Build strong immunization programmes
3.1
Deliver across the life course
What Does this Indicator Measure?
This indicator shows the proportion of targeted population that received the relevant vaccine and dose in that year for DTP (diphtheria-tetanus-pertussis), measles, pneumococcal disease, and HPV.
How Will Progress be Measured?
Globally, the IA2030 target is 90% for coverage of these four vaccines. Using the WHO and UNICEF estimates of national immunization coverage (WUENIC), the indicator will be evaluated annually at the global and regional level.
Vaccination coverage across the life course—Global
First Year — DTP3
86.0%
2019
Baseline
83.0%
2020
81.0%
2021
2030 Target
90%
First Year — PCV3
50.0%
2019
Baseline
51.0%
2020
51.0%
2021
2030 Target
90%
Second Year — MCV2
71.0%
2019
Baseline
72.0%
2020
71.0%
2021
2030 Target
90%
Adolescents — HPVc
14.0%
2019
Baseline
12.0%
2020
12.0%
2021
2030 Target
90%
Summary Table
| Vaccine | 2019 | 2020 | 2021 |
|---|---|---|---|
| DTP3 | 86% | 83% | 81% |
| PCV3 | 50% | 51% | 51% |
| MCV2 | 71% | 72% | 71% |
| HPVc | 14% | 12% | 12% |
Definition:
Immunization coverage for DTPcv-3, MCV-2, PCV3, and HPVc.
Measurement approach: Immunization coverage for a certain year is defined as the proportion of the targeted population that received the relevant vaccine and dose in that year.
Measurement will be determined at the regional and global levels, using WHO and UNICEF estimates of national immunization coverage (WUENIC). Note that for WUENIC, the annually targeted population for globally recommended vaccines comprises the entire global cohort of surviving infants, regardless of whether the vaccine was introduced in their country.
Calculation: Denominator is the estimated population of the target group of children that should receive DTPcv-3, MCV-2, PCV3, and HPVc. The numerator consists of the target population who have received DTPcv-3, MCV-2, PCV3, and HPVc. The target population of children and their appropriate age for receiving the last vaccine dose is determined by national immunization schedules.
Data source: WHO/UNICEF Estimates of National Immunization Coverage (WUENIC)
